Acquirersmultiple·2025-11-19 23:06Core Insights - Pzena Investment Management LLC maintains a disciplined value investment strategy with a total portfolio value of $30.94 billion as of September 30, 2025, focusing on cyclical recoveries and normalized earnings power [1] Top Holdings - Magna International Inc. (MGA) leads the portfolio with a value of $1.92 billion, representing 6.19% of total assets, despite a slight reduction of 434,000 shares (–1.5%) [2] - Baxter International Inc. (BAX) follows with $1.31 billion (4.22%), having added 18 million shares (+45.9%), reflecting confidence in its restructuring and margin recovery [3] - Citigroup Inc. (C) is third at $1.27 billion (4.11%), with a reduction of approximately 1 million shares (–7.7%), indicating a belief in the bank's undervaluation [4] - Dollar General Corp. (DG) ranks fourth at $1.21 billion (3.9%), with a minor reduction of 171,000 shares (–1.5%), aligning with Pzena's preference for cash-generating franchises [5] - CVS Health Corp. (CVS) holds $1.19 billion (3.86%), having sold 901,000 shares (–5.4%), fitting the model of steady cash flows during market pessimism [6] Other Key Adjustments - Modest increases were noted in Cognizant Technology Solutions (CTSH) (+1.5%) and MetLife (MET) (+5.8%), while Wells Fargo (WFC) and Capital One (COF) were slightly trimmed, indicating fine-tuning rather than thematic shifts [7] - Humana (HUM) remains a significant healthcare position at $1.05 billion (3.39%), with a slight reduction [7] Full Exits - The quarter saw complete disposals of smaller positions including Shyft Group (SHYF), Synovus Financial (SNV), NatWest Group (NWG), ICICI Bank (IBN), Ulta Beauty (ULTA), and Alkermes (ALK S), reflecting a consolidation towards higher-conviction U.S. large-caps [8] Outlook - Pzena's Q3 2025 update highlights its status as a deep-value investor in a growth-focused market, with significant additions to Baxter and stable positions in Magna and Citigroup, emphasizing a commitment to low-multiple, high-cash-flow companies [9]